Assistant

Ask questions, navigate pages, or type / for commands

Ask
Navigate
Command

Bausch Health Companies Inc. BHC.TO

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · bauschhealth.com

Bausch Health Companies Inc. is a global diversified healthcare company headquartered in Laval, Quebec, that develops, manufactures, and markets products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, and eye health. The company operates through its majority-owned subsidiary Bausch + Lomb Corporation and serves patients and healthcare providers worldwide with a team of over 7,000 employees.

Key ratios
FreeCashFlowOnSale TTM 0.1
FreeCashFlowOnSale 2025 0.1
FreeCashFlowOnSale 2024 0.13
FreeCashFlowOnSale 2023 0.09
NetIncomeMargin TTM 0.02
NetIncomeMargin 2025 0.02
NetIncomeMargin 2024 -0
NetIncomeMargin 2023 -0.07
ReturnOnAssets TTM 0.05
ReturnOnAssets 2025 0.05
ReturnOnAssets 2024 0.04
ReturnOnAssets 2023 0.04
ReturnOnEquity TTM 4.36
ReturnOnEquity 2025 4.36
ReturnOnEquity 2023 -6.87
Recent news
Bausch Health Announces Second Quarter 2026 Results, Raises Guidance 2026-07-29 · CNW
ELIDEL (pimecrolimus) cream Now Reimbursed Under Alberta's Public Drug Plan 2026-07-28 · CNW
Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026 2026-07-07 · Newswire (CNW)
Québec is the first province to list (Pr)OKEDI(MC) on the public drug reimbursement formulary for the treatment of schizophrenia 2026-07-06 · Newswire (CNW)
Michael Goettler Resigns from Bausch Health's Board of Directors 2026-07-01 · PR Newswire
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance sign letter of intent for public drug plan coverage of PrOKEDI® (Risperidone for extended-release injectable suspension) for the treatment of schizophrenia 2026-06-09 · Bausch Health IR
An unhandled error has occurred. Reload 🗙